Retail network access is facilitated through agreements with United Networks of America (UNA). Display of pharmacy brand marks does not imply ownership, endorsement, or direct partnership with XRP Healthcare M&A Holding Inc.
Technology partnerships reflect collaborative or project-based cooperation. Display does not imply equity ownership or endorsement unless expressly stated.
Pharmaceutical and supply relationships reflect existing commercial arrangements within acquired operating entities. Display does not imply exclusivity or endorsement beyond standard commercial supply agreements.
Advisors provide professional services to XRP Healthcare M&A Holding Inc. No partnership or ownership interest is implied unless publicly disclosed.
All third-party trademarks remain the property of their respective owners. Display does not imply endorsement, ownership, or partnership unless expressly stated.
Nov 24, 2022
The global cannabis market is poised for substantial growth, expected to surge from $28.266 billion to a remarkable $197.74 billion by 2028. However, the current landscape presents challenges for numerous cannabis
The global cannabis market is poised for substantial growth, expected to surge from $28.266 billion to a remarkable $197.74 billion by 2028. However, the current landscape presents challenges for numerous cannabis companies. Several Australian firms, for instance, have experienced abrupt account terminations by banks. This predicament underscores the persistent concerns surrounding banking within the realm of MRBs (marijuana-related businesses). While attitudes towards MRBs have improved, the banking sector remains sluggish in its response.
The reluctance to provide banking services has severely impeded the industry, as legitimate enterprises are unable to operate legally without access to bank accounts. In the United States, cannabis businesses grapple with significant restrictions due to federal laws that still impede the sale and distribution of marijuana.
According to analysis conducted by POLITICO on two dozen of the largest publicly traded U.S. operators, these companies collectively incurred losses exceeding $550 million in the first half of the year, despite generating revenues of nearly $4.5 billion [1]. As the industry awaits congressional approval of the SAFE (Secure and Fair Enforcement) Banking Act, U.S. cannabis companies continue to face hurdles in accessing banking services and electronic payment systems. Blockchain solutions like XRPH have the potential to revolutionize the industry by enabling the comprehensive tracking and tracing of cannabis products throughout their entire lifecycle and facilitating secure and rapid payment systems.
With limited access to traditional banking services and electronic payments, digital payment solutions are becoming increasingly attractive to MRBs. Cryptocurrencies emerge as a natural solution, as cryptocurrency exchanges are not subject to the same regulations as traditional banks. This makes it significantly easier for companies to access cashless transactions, conduct international payments, benefit from lower fees, and utilize trackable services. XRP Healthcare offers a comprehensive suite of solutions that address these challenges, all executed on the XRP Ledger, known for its robust anti-counterfeiting capabilities.
The ongoing development of XRPH's marketplace promises to provide the necessary tools to address the aforementioned issues confronting MRBs in the cannabis industry.